Burn

EQS-News: OHB prime contractor for development and assembly of the LEO-PNT navigation demonstration satellites

Retrieved on: 
Wednesday, April 10, 2024
LEO, European Space Agency, EUR, Burn, Algorithm, Galileo Galilei, ESA, Navigation, FOC, OHB, CubeSat, GMV, Orbit, Communications satellite

The contract between the client ESA (European Space Agency) and GMV was signed this week in Paris.

Key Points: 
  • The contract between the client ESA (European Space Agency) and GMV was signed this week in Paris.
  • OHB is working on this mission as a subcontractor to GMV: OHB’s share of the total contract is valued at around EUR 38 million.
  • OHB is contributing to the LEO-PNT programme the expertise that it gained from the European Galileo navigation satellite programme, for whose 34 FOC (Full Operational Capability) satellites it is the prime contractor.
  • LEO-PNT is an in-orbit demonstration mission, as various parameters are to be tested during this mission.

Believe It or Not! Total Solar Eclipse Captured for Ripley’s Exhibit Collection

Retrieved on: 
Monday, April 8, 2024
Eclipse, Burn, Projection, Apollo, Science, Moon, Collection, Sunlight, Lens, Movement, American Eclipse, Renewable energy

Blending science, art, and ancient photographic techniques, Michael Papadakis, also known as @Sunscribes , captured the total solar eclipse in his signature way — harnessing the power of the sun to create an unbelievable piece of art for Ripley’s exhibit collection.

Key Points: 
  • Blending science, art, and ancient photographic techniques, Michael Papadakis, also known as @Sunscribes , captured the total solar eclipse in his signature way — harnessing the power of the sun to create an unbelievable piece of art for Ripley’s exhibit collection.
  • “With an event as rare as the Great North American Eclipse — only the second total solar eclipse in the U.S. in less than seven years — we knew we needed to capture it for the Ripley’s collection in some way,” said Director of Ripley’s Exhibit Collection, John Corcoran.
  • But, immortalizing the fleeting moments of a total solar eclipse and transforming them into a masterpiece is no easy task.
  • Papadakis’ total solar eclipse piece will soon on go display where it was created — at Ripley’s Believe It or Not!

Tunnel to Towers Foundation Delivers Mortgage-Free Homes to Five Gold Star Families

Retrieved on: 
Friday, April 5, 2024
Burn, Pressure, Tunnel, SSG, Cancer, Gold Star, United States Army, Gold, Family, Army

New York, New York, April 05, 2024 (GLOBE NEWSWIRE) -- The Tunnel to Towers Foundation is observing Gold Star Spouses Day by delivering mortgage-free homes to five families who lost loved ones in service to our country.

Key Points: 
  • New York, New York, April 05, 2024 (GLOBE NEWSWIRE) -- The Tunnel to Towers Foundation is observing Gold Star Spouses Day by delivering mortgage-free homes to five families who lost loved ones in service to our country.
  • Tunnel to Towers wants these families to know their loved one's service and sacrifice has not been forgotten,” said Frank Siller Chairman and CEO of the Tunnel to Towers Foundation.
  • “I am so grateful to receive Tunnel to Towers support on Gold Star Spouse Day.
  • Join Tunnel to Towers on its mission to provide mortgage-free homes for Gold Star families by going to T2T.org and donating $11 a month.

Recce Pharmaceuticals Granted New Patent in Israel for RECCE® Anti-Infectives

Retrieved on: 
Thursday, April 4, 2024
Escherichia coli, Central Bureau, Statistics, Burn, PCT, Shingles, Biotechnology, Growth, Disease, HIV, Klebsiella pneumoniae, COVID-19, Inhalation, HCMV, ASX, RCE, Recce, Viral, Pseudomonas aeruginosa, Virus, EBV, SARS-CoV-2, Staphylococcus aureus, Gonorrhea, Cytomegalovirus, Ross River virus, Neisseria meningitidis, GDP, Urinary tract infection, Skin, Streptococcus pyogenes, Patent, Staphylococcus, Streptococcus pneumoniae, Simplex, Infection, USD, Administration, Biology, Ageing, Pharmaceutical industry

SYDNEY, Australia, April 04, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, today announced that the State of Israel Patent Office has formally granted Recce a new family four patent (patent number: 295116), “Process for Preparation of Biologically Active Copolymer Comprising an Acrolein Derivative and a Polyalkylene Glycol Oligomer,” with expiry in 2041.

Key Points: 
  • SYDNEY, Australia, April 04, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, today announced that the State of Israel Patent Office has formally granted Recce a new family four patent (patent number: 295116), “Process for Preparation of Biologically Active Copolymer Comprising an Acrolein Derivative and a Polyalkylene Glycol Oligomer,” with expiry in 2041.
  • “We are thrilled to have received this newly granted patent in Israel,” said James Graham, Chief Executive Officer of Recce Pharmaceuticals.
  • Israel’s pharmaceuticals and biotechnology market has a reputation for high R&D spending and an impressive international reach, with world-class export numbers and a growing market value.
  • Other examples include influenza A, Ross River virus, and coronaviruses, including those responsible for severe acute respiratory syndrome and SARS-CoV-2 (COVID-19).

Tilray Brands Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup

Retrieved on: 
Thursday, April 4, 2024
Melon, Cream, CBG, Culture, Burn, Limonene, Hibiscus, Gasoline, TLRY, Snow, Partnership, Lotus, CBD, GOOD, TSX, Love, Cranberry, Cheese, Fruit, Ammonia, Candy, THC, Citrus, Drug

TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis lifestyle and consumer packaged goods company, through its wholly-owned licensed subsidiaries, Aphria Inc., Hexo Operations Inc., and Truss Beverages Company Limited, announces its latest product lineup and 420 celebratory activations across Canada.

Key Points: 
  • TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis lifestyle and consumer packaged goods company, through its wholly-owned licensed subsidiaries, Aphria Inc., Hexo Operations Inc., and Truss Beverages Company Limited, announces its latest product lineup and 420 celebratory activations across Canada.
  • Cannabis enthusiasts and cannabis-curious consumers alike are invited to learn about Tilray Brands’ products at local cannabis retailers.
  • In celebration of 420 and the ever-changing landscape of cannabis innovation and culture, Tilray Brands invites consumers to explore a new range of diverse cannabis products from its leading brands.
  • Broken Coast EmergenZ and Cherry Cheesecake: Broken Coast presents two exceptional strains for 420 with unique aromas and taste profiles.

Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer

Retrieved on: 
Monday, April 1, 2024
Burn, Brigham Young University, Avita Medical, MDAI, Business administration, Patient, Global strategy, Artificial intelligence, Spectral, Publication, Master of Business Administration, Health Economics, Johnson & Johnson, Allergan, Government, Physician, Medtech

DALLAS, April 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Jeremiah A. Sparks as Chief Commercialization Officer.

Key Points: 
  • DALLAS, April 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Jeremiah A. Sparks as Chief Commercialization Officer.
  • Jeremiah has more than 20 years of medical device marketing experience, including global marketing and business strategy.
  • Mr. Sparks will be responsible for both domestic and international product commercialization.
  • “We are thrilled to have Jeremiah join the company as we move towards commercialization of DeepView,” said Peter M. Carlson, CEO of Spectral AI.

CoinRaffle.io Unveils Innovative Platform for Secure and Fair Decentralized Raffles

Retrieved on: 
Friday, March 29, 2024
Ethereum, Dapp, Blockchain, Privacy, Burn, Growth, Policy, Cryptocurrency

Willemstad, Curaçao, March 29, 2024 (GLOBE NEWSWIRE) -- The CoinRaffle.io project has proudly launched its utility-focused platform, which relies on decentralized technology.

Key Points: 
  • Willemstad, Curaçao, March 29, 2024 (GLOBE NEWSWIRE) -- The CoinRaffle.io project has proudly launched its utility-focused platform, which relies on decentralized technology.
  • This innovative solution enables projects to host community raffles with ease, transparency, and fairness.
  • Developed by VTS Blockchain Engineers for CoinRaffle Inc., the platform represents the future of decentralized community engagement.
  • Users can view past raffles in "My Raffles" by connecting their wallet to the platform.

Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results

Retrieved on: 
Wednesday, March 27, 2024
De novo, DFU, Diabetic foot ulcer, Certification, Burn, Government, Development, FY, MDAI, Patient, Research, History, Artificial intelligence, Classification, Sale, Standard of care, Human services, Research and development, Wound healing, Trial of the century, Clinical trial, ASPR, ISO, FDA, Administration, Food, Pharmaceutical industry

DALLAS, March 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter (“Q4 2023”) and full year (“FY 2023”) ended December 31, 2023 and provided an update on its ongoing business activities.

Key Points: 
  • DALLAS, March 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter (“Q4 2023”) and full year (“FY 2023”) ended December 31, 2023 and provided an update on its ongoing business activities.
  • “Spectral AI achieved much in 2023, and our progress along multiple fronts has continued into 2024,” said Peter M. Carlson, Chief Executive Officer.
  • “
    In September 2023, we were awarded the largest contract in our history from the US Government valued at up to $150.0 million.
  • All comparisons to Q4 2023 and FY 2023 are to the comparable periods ended December 31, 2022, unless otherwise stated.

Mobilicom Reports 2023 Year-End Financial Results

Retrieved on: 
Tuesday, March 26, 2024
Burn, Intelligence, Aviation, Software, ICE, Unmanned aerial vehicle, Robotics, Atmosphere, Traction, Ministry, Ministry of Defense (Israel)

SHOHAM, Israel, March 26, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or “Company”), a provider of cybersecurity and robust solutions for drones and robotics, today announced financial results for the year ended December 31, 2023.

Key Points: 
  • SHOHAM, Israel, March 26, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or “Company”), a provider of cybersecurity and robust solutions for drones and robotics, today announced financial results for the year ended December 31, 2023.
  • “2023 was a transformative year for Mobilicom marked by several initial commercial scale orders from large global defense manufacturers.
  • Our cybersecure systems are now integrated into drones and robotics purchased by the U.S. Department of Defense, Israel’s Ministry of Defense and others” stated Mobilicom CEO and Founder Oren Elkayam.
  • United Arab Emirates (UAE): Mobilicom secured a repeat order for its robust end-to-end solutions from a leading UAE government organization.

Elixir Games Unveils Inaugural Season Pass Airdrop with Over $1M Prizes

Retrieved on: 
Tuesday, April 9, 2024
Season, Burn, Season ticket, Social media, Non-fungible token, Enix, Collection, MiNT, Cryptocurrency

BARCELONA, Spain, April 9, 2024 /PRNewswire/ -- Elixir Games, a web3 gaming platform backed by Square Enix with over 1 million users on the Elixir Launcher, today announced its Season Pass Airdrop with over $1 million in prizes for participants. Running from April 19th to June 3rd, with a pre-season starting on April 12th, this event promises to redefine the gaming experience for enthusiasts worldwide.

Key Points: 
  • Elixir Games launches its biggest web3 gaming event to date, offering massive rewards to its community
    BARCELONA, Spain, April 9, 2024 /PRNewswire/ -- Elixir Games, a web3 gaming platform backed by Square Enix with over 1 million users on the Elixir Launcher, today announced its Season Pass Airdrop with over $1 million in prizes for participants.
  • The Season Pass will feature quests on the Elixir Launcher, both within the platform and in participating games, including major titles such as Chronos Worlds, Elemental Raiders, Mokens League, and many others.
  • "Elixir's inaugural Season Pass promises to be an exciting and opportunity-filled experience for players worldwide," said Carlos Roldan, CEO of Elixir Games.
  • For more information about Elixir Games Season One Airdrop, as well as how to join the waitlist for the Freemint NFT launch, please visit: https://launchpad.elixir.games/